The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according ...

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a recent review article.

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, into molecular subtypes using ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the ...

A new publication by a national collective of researchers has highlighted the potential for the use of artificial intelligence (AI) in identifying ...

Icad (NASDAQ: ICAD) Presents Four AI-Driven Breast Cancer Research Abstracts at the 2024 San Antonio Breast Cancer Symposium ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen treatment burdens.

A HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...

Project EVOLVE, funded by Daiichi Sankyo and AstraZeneca, to be presented at the 2024 San Antonio Breast Cancer Symposium -- NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Novellia, Inc., an AI-enabled ...

More than 100 000 women older than 70 years are diagnosed with hormone receptor-positive, early-stage breast cancer each year in the USA.1 A large proportion are at low risk of disease recurrence, ...

Data from a late-stage study shows that LLY's experimental oral drug benefited certain breast cancer patients when used as ...